Market Place
Sourcing Support
Bausch & Salix Present RED-C Study Design at AASLD Meeting
18 Nov 2024 //
ACCESSWIRE
ACG Plenary to Analyze Xifaxan® Risk Reduction in OHE
27 Oct 2024 //
ACCESSWIRE
Bausch Health Survey Highlights Need For Liver Disease Education
08 Oct 2024 //
ACCESSWIRE
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
20 Jun 2024 //
ACCESSWIRE
Salix Presents Phase 2 Amiselimod UC Data At DDW 2024
17 May 2024 //
ACCESSWIRE
Salix runs Xifaxan TV spot with `Scandal` actor Bellamy Young
10 May 2024 //
FIERCE PHARMA
Salix Announces Bellamy Young As Xifaxan Spokesperson
09 May 2024 //
ACCESSWIRE
Salix Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R)
06 Mar 2024 //
ACCESSWIRE
Salix Announces 2024 Gastrointestinal Health Scholars Program
12 Feb 2024 //
ACCESSWIRE
Bausch’s Salix initiates first awareness day for opioid-induced constipation
05 Dec 2023 //
ENDPTS
Salix co-creates awareness day for opioid-induced constipation
05 Dec 2023 //
FIERCE PHARMA
Bausch notches win in Xifaxan case against Alvogen
03 Nov 2023 //
FIERCE PHARMA
Salix Pharmaceuticals Releases Liver Health Annual Trends Report
10 Oct 2023 //
ACCESSWIRE
Salix tackles stigma around brain condition caused by acute liver disease
05 Oct 2023 //
ENDPTS
Salix Pharmaceuticals Partners with Bellamy Young
04 Oct 2023 //
ACCESSWIRE
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
11 Jul 2023 //
ACCESSWIRE
Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL`s ™
19 Jun 2023 //
ACCESSWIRE
Salix donates bowel prep treatment to help with charity project
11 May 2023 //
FIERCE PHARMA
Salix Pharma To Deliver Podium Presentation At Digestive Disease Week® 2023
08 May 2023 //
PRESS RELEASE
Salix Partners with Colorectal Cancer Alliance on Community Screening Program
24 Apr 2023 //
ACCESSWIRE
Salix survey shows many IBS patients suffer in silence for years
05 Apr 2023 //
FIERCE PHARMA
Salix Announces 2023 Gastrointestinal Health Scholars Program
13 Feb 2023 //
ACCESSWIRE
Salix Will Present XIFAXAN(R, TRULANCE and RELISTOR Data at Scientific Meeting
24 Oct 2022 //
ACCESSWIRE
Salix report finds rising death rates from chronic liver disease
17 Oct 2022 //
FIERCEPHARMA
Salix Pharmaceuticals Releases Liver Health Annual Trends Report
12 Oct 2022 //
PRNEWSWIRE
Salix Supports CMS Announcement of First ICD-10 Code
10 Aug 2022 //
PR NEWSWIRE
Pain drug stigma stops patients from getting meds
05 Aug 2022 //
FIERCEPHARMA
Salix Announces 2022 Gastrointestinal Health Scholars Program Winners
13 Jul 2022 //
PRNEWSWIRE
Salix to Share New Data from XIFAXAN Clinical Research at EASL 2022
20 Jun 2022 //
PRNEWSWIRE
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
18 May 2022 //
PRNEWSWIRE
Salix Pharma Will Present Scientific Data At SHMC 2022
07 Apr 2022 //
PRNEWSWIRE
New Data on Cost Impact of Treating OIC with FDA-Approved Medications
24 Mar 2022 //
PRNEWSWIRE
Mylan Entities Trimmed From Bausch Trulence Infringement Suit
11 Mar 2022 //
BLOOMBERGLAW
Salix pilots study to shine light on chronic liver disease
26 Oct 2021 //
ENDPTS
New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients
25 Oct 2021 //
PRNEWSWIRE
Salix Will Present Scientific Data Featuring Post Hoc Analyses For RELISTOR®
13 May 2021 //
PRNEWSWIRE
Salix shines a light on IBS patients` pandemic suffering
29 Apr 2021 //
FIERCE PHARMA
Salix Launches GastroHub for Advanced Practice Providers, an Educational Website
30 Mar 2021 //
PRNEWSWIRE
Salix To Present Data At AASLD`s The Liver Meeting Digital Experience
11 Nov 2020 //
PRNEWSWIRE
Bausch Health`s Rifaximin Receives FDA Orphan Designation Sickle Cell Disease
29 Oct 2020 //
PRNEWSWIRE
Salix To Present Data For Products Across Its Portfolio At
22 Oct 2020 //
PRNEWSWIRE
Salix To Present Data For Products Across Its Portfolio At Gastroenterology
21 Oct 2020 //
PRNEWSWIRE
Salix To Present Clinical Data At United European Gastroenterology Week 2020
08 Oct 2020 //
PRNEWSWIRE
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program
15 Jun 2020 //
PRNEWSWIRE
Salix To Highlight New Data Across Its Portfolio Products At Digestive Disease
30 Apr 2020 //
PRNEWSWIRE
RedHill Biopharma Regains Rights to its Proprietary Bowel Preparation RHB-106
02 Jan 2020 //
PRESS RELEASE
Alfasigma USA Reintroduces IBS-C Drug Zelnorm to U.S. Market
13 Sep 2019 //
BIOSPACE
Bausch loses Salix president to precision GI company
06 Sep 2019 //
FIERCE PHARMA
Can Dova take on Novartis? With its 2nd Doptelet nod and a price cut, maybe so
29 Jun 2019 //
FIERCE PHARMA
Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug
26 Apr 2019 //
FIERCEBIOTECH
Salix Enters Into License Agreement With The University Of California
31 Mar 2019 //
PRESS RELEASE
Salix Announces 2 Methylnaltrexone Poster for Opioid-Induced Constipation
13 Mar 2019 //
PR NEWSWRE
Uceris (budesonide) : Valeant Pharmaceuticals, Salix Pharmaceuticals vs. Sun Pharmaceutical Industries
13 Dec 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Apotex
01 Nov 2018 //
PATENT LITIGATION
SEC charges Bausch Health`s subs Salix with misleading investors
29 Sep 2018 //
CNBC
SEC Charges Salix Pharmaceuticals and Former CFO
28 Sep 2018 //
SEC
Uceris (budesonide) : Valeant Pharmaceuticals et al v. Teva Pharmaceuticals et al
27 Aug 2018 //
PATENT LITIGATION
Valeant touts Salix salesforce scale-up amid rumors of mass rep exit
27 Feb 2017 //
FIERCE PHARMA
Lupin gets FDA Nod to Market Ulcerative Colitis Tablets in US
30 Dec 2016 //
ECONOMIC TIMES
Valeant’s 2016 Has Been All Pain, No Gain Amid Record Stock Drop
16 Dec 2016 //
BLOOMBERG
